GLP-1 Pricing · Zepbound · Cost Intelligence · Last verified: April 15, 2026

By The RX Index Editorial Team · Last verified: April 15, 2026 · Affiliate disclosure · Editorial standards

Zepbound Savings Card 2026: Who Gets $25, Who Pays $499 or $299, and What to Do Next

The Zepbound Savings Card is real, it’s free, and it still exists in 2026 — but the “as low as $25” headline only applies if your commercial insurance covers the Zepbound single-dose pen. If your commercial plan doesn’t cover the pen, Lilly’s official card drops your cost to as low as $499/month. If you’re being filled as the KwikPen instead, the price is $299 / $399 / $449 depending on dose. If you’re on Medicare, Medicaid, TRICARE, or VA, you cannot use the commercial Savings Card — but you have other legitimate paths starting at $50/month.

The single most common way people get hurt here: they search “zepbound savings card,” land on a page that says “pay $25 with the savings card,” walk into CVS expecting $25, and leave with a $700 receipt because the pharmacy ran it on the wrong device path or their plan doesn’t actually cover Zepbound. This page will prevent that.

What you actually pay in 2026, by situation and device

We built this matrix after reading every current Eli Lilly savings term. Most competing pages haven’t caught up to 2026. This is the first table that cleanly separates every Zepbound device and insurance path with the real catches attached.

Sources: Lilly’s savings terms document (CMAT-05333 03/2026); zepbound.lilly.com/savings; zepbound.lilly.com/hcp/coverage-savings. All verified April 2026.

What we actually verified for this page

We don’t trust the SERP on this query. Too many pages still publish outdated numbers. Here’s what we checked for this version:

• ✅Lilly's live Coverage, Affordability, and Savings page at zepbound.lilly.com/hcp/coverage-savings (April 2026)
• ✅Lilly's consumer Savings Options page at zepbound.lilly.com/savings (April 2026)
• ✅Lilly's full Terms and Conditions document (CMAT-05333 03/2026)
• ✅Lilly's Pricing Info page at pricinginfo.lilly.com/zepbound for current wholesale acquisition cost
• ✅Lilly's Access & Coverage page at zepbound.lilly.com/access-coverage for prior auth and appeal resources
• ✅CMS Medicare GLP-1 Bridge FAQ at cms.gov (updated April 2026)
• ✅TrumpRx pricing at trumprx.gov/p/zepbound and trumprx.gov/p/zepbound-kwikpen (April 2026)
• ✅Current FDA-approved indications for Zepbound: chronic weight management and moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity — not type 2 diabetes (that's Mounjaro)

Who qualifies for the Zepbound Savings Card in 2026?

You qualify for the covered $25 tier if you have commercial drug insurance that covers the Zepbound single-dose pen, a valid prescription for an FDA-approved indication, are 18 or older, and live in the US or Puerto Rico. If your commercial plan doesn’t cover Zepbound, separate card tiers drop your cost to $499 (pens) or $299–$449 (KwikPen). Government insurance — Medicare, Medicaid, TRICARE, VA, IHS — is excluded from the commercial Savings Card.

The four eligibility paths, stripped of the marketing language

The quieter disqualifier: AFP (Alternate Funding Programs)

Some commercial insurance plans run an Alternate Funding Program — a third-party vendor that tries to enroll high-cost specialty drug patients in manufacturer assistance to reduce the plan’s own cost. Lilly’s terms bar patients in these programs from using the Savings Card. If your employer plan recently started routing you to a “patient advocate” offering to “help” with financial assistance, that may be an AFP. Call Lilly support at 1-866-923-1953 to confirm.

A short and honest note about the annual cap

The 2026 annual cap on the covered tier is $1,300 — a decrease from earlier years. For most people with Zepbound coverage whose actual copay after insurance is well under $100, this cap may never matter in practice. But for people with partial coverage whose copay runs above $100/month, you’ll hit that $1,300 cap in the fall and pay your full plan copay for the remaining fills. Plan for this if your copay lands between $100 and $200.

How much is Zepbound with the Savings Card? (Exact dollar math)

With commercial coverage for the single-dose pen, eligible patients can pay as little as $25 per 1-, 2-, or 3-month fill, with Lilly capping its contribution at $100/month and $1,300/year. Without coverage, the card brings single-dose pens to as low as $499/month. The KwikPen (commercial non-covered or self-pay) ranges from $299 to $449 by dose. For comparison, Zepbound’s list price is $1,086.37/month at Lilly’s published wholesale acquisition cost.

What that looks like across a full year

Note: KwikPen card is capped at 11 fills/year — not the 13 fills allowed on the single-dose pen card. A “month” for the KwikPen is 28 days and up to 1 KwikPen (vs 4 single-dose pens for the pen card).

What happens if you miss the 45-day refill window on LillyDirect?

For the Self-Pay Journey Program (vials or KwikPen at higher doses), Lilly requires you to refill within 45 days of your previous delivery to maintain the $449 price. Miss it and the price jumps significantly:

How to activate the Zepbound Savings Card

Go to zepbound.lilly.com/savings, enter your information, attest that you meet the eligibility criteria, and receive a digital card with BIN, PCN, and Group numbers that the pharmacy needs to process the discount. Lilly also maintains a separate activation site at lillycardactivation.com. If you had a 2025 card, it expired 12/31/2025 — you’ll need to re-enroll and accept the updated 2026 terms.

1. Visit zepbound.lilly.com/savings from any phone or desktop.
2. Enter your details and confirm you meet the eligibility criteria — commercial insurance, valid Zepbound prescription for an FDA-approved use, 18+, US/PR resident, not on a government plan.
3. Receive your digital card with four critical numbers: Card ID, BIN, PCN, and Group. Save it to your phone and keep a backup.
4. If prompted, activate separately at lillycardactivation.com.

Keep those four numbers accessible. The pharmacy will need all of them, and some systems require the pharmacist to enter them manually.

How to use the card at the pharmacy

Hand the pharmacist both your commercial insurance card and your Zepbound Savings Card. Ask them to run your insurance first, then apply the Savings Card as a secondary claim using coordination of benefits, with the BIN, PCN, and Group numbers from your card. The discount should apply automatically through the pharmacy claims system.

If the pharmacist looks uncertain, that’s common. Manufacturer copay cards are processed as a secondary insurance claim, not as a coupon. Don’t leave — that moment of “let me figure this out” is where most of the $700 pharmacy stories start. Wait, read them the numbers, and if they still can’t process it, call Lilly support from the counter.

Why your Zepbound Savings Card isn’t working at the pharmacy

The most common reason is the pharmacy processed the card alone instead of as a secondary claim after insurance. Other frequent causes: the card wasn’t activated, the device being filled is on a different card tier than the pharmacist entered, the plan uses a copay accumulator or alternate funding program, or the patient has government insurance on file. Each failure has a specific fix.

Before the troubleshooting table, here’s what real people report. These are actual quotes from the public r/Zepbound subreddit — shared as anecdotal checkout experiences, not as verified Lilly policy:

What those three quotes have in common: the problem was never “the card is fake.” The card worked fine in January. Then the pharmacy processing broke, or the device path changed, or the deductible reset. Here’s the decoder:

Common pharmacy issues and how to handle them

Does the Savings Card work on the single-dose pen, KwikPen, or vials?

The Savings Card covers both the single-dose pen and the KwikPen, but with different terms, different fill limits, and different price tiers. Lilly explicitly states the $299 savings card applies to the Zepbound KwikPen and not the single-dose pen. Single-dose vials are accessed through the LillyDirect Self-Pay Journey Program — a separate cash-pay program, not the Savings Card. Confusing these devices is the #1 reason people get quoted the wrong price.

Here’s how it actually breaks down:

LillyDirect vs the Savings Card at a retail pharmacy

LillyDirect is Lilly’s direct-to-patient pharmacy platform — it ships KwikPen or vials to your door, uses its own fixed cash pricing, and doesn’t involve a savings card at all. The Savings Card is what you use at a retail pharmacy (CVS, Walgreens, Kroger, etc.) alongside your commercial insurance. They’re different programs with different pricing structures, and you can’t use both at once.

If you’re a cash patient with no insurance, LillyDirect is usually the simpler path — no card activation, no pharmacy confusion, no coordination of benefits. The prescription goes straight to LillyDirect and the medication ships to you.

Can you use the Savings Card without insurance, with Medicare, or with Medicaid?

The commercial Savings Card requires commercial insurance. If you have no insurance, you can use the KwikPen Self-Pay Savings Card ($299–$449) or the LillyDirect Self-Pay Journey Program ($299–$449) — same pricing, different programs. If you have Medicare, Medicaid, TRICARE, or VA, you cannot use the commercial Savings Card because federal anti-kickback law prohibits it — but Lilly’s consumer savings page still routes government-plan patients to self-pay pricing starting at $299. The Medicare GLP-1 Bridge starts July 1, 2026 with a $50/month copay for eligible Part D beneficiaries.

If you’re on Medicare

You have three real paths:

1. LillyDirect Self-Pay Journey Program — $299 for the 2.5 mg dose, $399 for 5 mg, $449 for 7.5–15 mg (KwikPen or vials). Must refill within 45 days to keep the higher-dose price. No prior authorization required. Available now.
2. TrumpRx — the government direct-to-consumer pricing platform at trumprx.gov. Lists Zepbound vials and KwikPen starting at $299. No insurance or income requirements. TrumpRx routes Zepbound orders through LillyDirect for fulfillment.
3. Medicare GLP-1 Bridge (starts July 1, 2026) — a short-term CMS demonstration running July 1 through December 31, 2026. Eligible Part D beneficiaries get Zepbound KwikPen only (not single-dose pens or vials) at a $50/month copay with no deductible. Eligibility requires BMI ≥35, or BMI ≥27 with qualifying comorbidities (heart failure, hypertension, chronic kidney disease, pre-diabetes, or cardiovascular history). Prior authorization is required through a CMS central processor, not your Part D plan. Note: the $50 copay does not count toward your Part D deductible or out-of-pocket spending cap.

If you’re on Medicaid

State-dependent and getting tighter. California’s Medi-Cal stopped covering Zepbound for weight loss and weight-loss-related indications as of January 1, 2026 — though prior authorization requests for Zepbound prescribed for OSA may still be considered. Several other states are reconsidering coverage. Check your state’s current formulary. The BALANCE Model opens to state Medicaid agencies beginning May 2026, which may expand access in participating states.

If you’re on TRICARE or VA

Government-funded, so the commercial Savings Card doesn’t apply. TRICARE has historically had limited GLP-1 coverage for weight loss; VA coverage varies by facility. Your cleanest self-pay paths are LillyDirect ($299–$449) or TrumpRx (starting at $299).

What if your commercial insurance denies Zepbound?

If your commercial plan denies Zepbound, you have three real options: (1) have your prescriber submit a prior authorization with clinical justification and a letter of medical necessity, (2) use the Savings Card’s non-covered tier at $499/month (pens) or $299–$449 (KwikPen) while you appeal, or (3) switch to LillyDirect self-pay at $299–$449/month if you’d rather stop fighting insurance. The denial is usually about formulary restrictions, not about whether you qualify clinically.

Why plans deny Zepbound even when it’s “covered”

• Prior authorization — your doctor has to submit paperwork proving you meet the plan’s clinical criteria (BMI thresholds, documented weight-loss attempts, comorbidity requirements).
• Step therapy — the plan wants you to try a cheaper alternative first (Wegovy, Saxenda, or a generic option).
• Quantity limits — you can only fill at certain intervals or quantities.
• Indication-based exclusion — some plans cover Zepbound for obstructive sleep apnea (FDA-approved indication) but not for obesity alone.

How to handle a denial

1. Get the denial letter. You need the specific reason — not just “not covered.” Ask for the written denial with the plan’s citation.
2. Your prescriber submits a PA or appeal. This typically includes a letter of medical necessity documenting your BMI, weight history, comorbidities, past weight-loss attempts, and clinical rationale for Zepbound specifically. Lilly publishes PA and appeal support resources at zepbound.lilly.com/access-coverage.
3. Check if OSA changes the picture. Zepbound is FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity. Some plans cover it for OSA even when they don’t cover it for obesity alone. If you have diagnosed OSA, make sure that’s documented in the PA.
4. Use the card while you wait. While your PA is pending, you can still enroll in the Savings Card. If the PA is approved, you’ll land in the $25 tier. If it’s denied, you’re at $499/month (pens) or $299–$449 (KwikPen). Either way, the card is cheaper than paying list price while you fight.

When to stop fighting insurance and switch to self-pay

Be honest with yourself about the tradeoff. If your plan is actively blocking Zepbound through an alternate funding program, if you’ve already appealed once and lost, or if the documentation bar is higher than you can clear — LillyDirect self-pay at $299–$449/month is often the cleaner answer. The monthly math is comparable to the $499 non-covered tier, and you skip the paperwork entirely. No prior authorization is required for LillyDirect self-pay.

See also: How to appeal a Zepbound denial · Cheapest Zepbound without insurance

Savings Card vs LillyDirect vs TrumpRx vs GoodRx: which is cheapest?

If you have commercial coverage for Zepbound, the Savings Card (as little as $25) wins by a wide margin. If your plan doesn’t cover Zepbound, the non-covered card tier ($499 pens / $299–$449 KwikPen) is usually cheapest. For cash and government-insurance patients, LillyDirect ($299–$449) and TrumpRx (starting at $299) are the cleanest paths. GoodRx (~$995 at Costco) is the most expensive legitimate option — only use it if nothing else is available.

Ranking pages still getting the Zepbound Savings Card wrong in 2026

Several top-ranking “Zepbound savings card” pages are publishing stale information that will cost you money at the pharmacy counter. We audited the current top results as of April 2026:

• SingleCare publishes a $1,950/year annual cap and claims non-covered patients save up to $469/fill. Lilly’s 2026 covered-tier annual cap is $1,300. Lilly now separates the $499 single-dose pen lane from the $299+ KwikPen lane — they are not the same program. (Verified against SingleCare’s published page, April 2026.)
• Drugs.com (last major update March 2025) still shows older savings amounts and states that Zepbound’s FDA-approved indication is type 2 diabetes in adults. That’s factually wrong — type 2 diabetes is Mounjaro’s indication. Zepbound is FDA-approved for chronic weight management and moderate-to-severe OSA in adults with obesity. (Verified against FDA label and Drugs.com’s published page, April 2026.)
• Ro’s own Zepbound coupon page cites the 12/31/2025 expiration and the old “$25 or $650” savings framing. The 2026 card runs through 12/31/2026 and uses different savings tiers. (Verified against Ro’s published page, April 2026.)

If you’ve been pricing Zepbound off any of those pages, that’s probably why your pharmacy number didn’t match. Drug pricing pages go stale fast — it’s the nature of this space. That’s why we re-verify this page quarterly.

Why your first fill of 2026 might cost more than expected

If you filled Zepbound cheaply in 2025 and suddenly got a higher bill in January, here’s what likely happened:

• Your deductible reset on January 1. Most commercial plans restart the deductible annually, so early fills of the year can be full-price until your deductible is met. The Savings Card still applies, but if your plan’s deductible is high, your “copay” before the card kicks in is large.
• Lilly’s 2026 terms changed. The monthly cap dropped to $100 (was higher in 2024–2025). If your true plan copay is between $100 and $200, your out-of-pocket went up even though “the card still works.”
• Your employer switched PBMs at renewal. Some PBMs block manufacturer cards at the processing level. If your benefits changed at the start of the year, that’s often the culprit.

The fix: run your first fill, confirm the actual price, call Lilly support if it’s unexpectedly high, and if the plan-level issue is structural, price out LillyDirect self-pay as your fallback.

Frequently asked questions about the Zepbound Savings Card